Home
NICE Guidance
Guidance and advice list
Published
In consultation
In development
Awaiting development
About NICE guidance
Status (In development)
Select status:
Published
In consultation
In development
Awaiting development
Apply
Filter by title (
enter title
)
Filter by title
Filter by title
View filters (0 in use)
Sort by: Title (A-Z)
Sort by:
Title (A - Z)
Title (Z - A)
Type (A - Z)
Type (Z - A)
Expected publication date (Newest)
Expected publication date (Oldest)
Apply sort
Clear filters
Clear filters
Apply filters
Filter by expected publication date
Please enter a valid month/year e.g. 01/2015
Pick a date between
March 2000
and
April 2029
From
To
Filter by area of interest
Antimicrobial prescribing
Covid-19
Filter by type
Guidance
NICE guidelines
Antimicrobial prescribing guidelines
Cancer service guidelines
Clinical guidelines
COVID-19 rapid guidelines
Medicines practice guidelines
Public health guidelines
Safe staffing guidelines
Social care guidelines
Diagnostics guidance
Health technology evaluations
Highly specialised technologies guidance
Interventional procedures guidance
Medical technologies guidance
Quality standards
Technology appraisal guidance
NICE advice
Evidence summaries
Key therapeutic topics
Medtech innovation briefings
Clear filters
Apply filters
Showing 1 to 10 of 592
In development NICE advice and guidance
Title
Type
Expected publication date
Sort date
Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]
Technology appraisal guidance
Expected publication date:
TBC
0
Abaloparatide for treating osteoporosis in postmenopausal women [ID882]
Technology appraisal guidance
Expected publication date:
TBC
0
Abatacept for preventing moderate to severe acute graft-versus-host disease after haematopoietic stem cell transplant in people 6 years and over [ID6185]
Technology appraisal guidance
Expected publication date:
TBC
0
Abemaciclib with abiraterone acetate and prednisone for treating hormone-relapsed metastatic prostate cancer [ID6230]
Technology appraisal guidance
Expected publication date:
TBC
0
Abicipar pegol for treating wet age-related macular degeneration ID1533
Technology appraisal guidance
Expected publication date:
TBC
0
ABP 959 (eculizumab biosimilar) for treating paroxysmal nocturnal haemoglobinuria TS ID 10250
Technology appraisal guidance
Expected publication date:
TBC
0
ABP-654 (ustekinumab biosimilar) for previously treated moderate to severe plaque psoriasis TS ID 11790
Technology appraisal guidance
Expected publication date:
TBC
0
Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768]
Technology appraisal guidance
Expected publication date:
TBC
0
Acute kidney injury: prevention, detection and management - Assessing risk factors for acute kidney injury in adults having iodine-based contrast media
NICE guideline
Expected publication date:
21 August 2024
20240821
Adrenal insufficiency: identification and management
NICE guideline
Expected publication date:
28 August 2024
20240828
Copy to clipboard